<qa>  What is the combination of pembrolizumab and RT feasible in the patient populationI. To establish that the combination of pembrolizumab and RT is feasible in the patient population and evaluate toxicities per National Cancer Institute NCI Common Toxicity Criteria for Adverse Events CTCAE version ver. 4.03. 